Heligenics, Inc.
PrivateLast Round
Grant
Feb 1, 2025
Total Funding Raised
$4.55M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Heligenics, Inc. is a biotechnology company that provides functional genomics research and drug discovery services using its proprietary GigaAssay™ technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Heligenics, Inc. Comparables
Compare Heligenics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Constantiam Biosciences | 86% | |
| Atlas Biotech | 83% | |
| Algen Biotechnologies | 78% |
Heligenics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 1, 2025 | ||||
| Seed | Jun 9, 2022 | ||||
| Seed | Dec 15, 2020 |
Heligenics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institutes of Health (NIH) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 13, 2026
Monthly visitors grew 56% MoM.
- Jul 27, 2026
Monthly visitors grew 364% MoM, reaching 1.9K.
Heligenics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Heligenics, Inc.'s valuation, stock price, and market status.
Is Heligenics, Inc. a public or private company?
Heligenics, Inc. is a private company.
What is the current stock price of Heligenics, Inc.?
Heligenics, Inc. is a private company, so its shares have no public market price. Caplight tracks Heligenics, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Heligenics, Inc. worth (valuation)?
Valuation information for Heligenics, Inc. is not publicly available.
Can I buy Heligenics, Inc. stock?
Heligenics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Heligenics, Inc.'s last funding round?
Heligenics, Inc.'s most recent funding round was Grant on February 1, 2025.
Who are the main investors in Heligenics, Inc.?
Key investors in Heligenics, Inc. include National Institutes of Health (NIH).
Will Heligenics, Inc. IPO soon?
No public IPO plans have been announced for Heligenics, Inc..
How can I track Heligenics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Heligenics, Inc.'s shares on secondary markets.